Navigation Links
Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce,Positive Results of Phase III Study for Milnacipran as a Treatment,for Fibromyalgia Syndrome

Overall premature discontinuation rates (all causes including adverse event related) were 35% for patients receiving 200mg per day of milnacipran, 34% for patients receiving 100mg per day of milnacipran and 28% for patients receiving placebo. The most common adverse events that led to early withdrawal among the milnacipran treated patients were nausea, palpitations, depression and headache, each of which occurred at a rate of less than 5%.

Future Development Plans

Subject to a favorable review of the full study results for the just completed trial and based in part on communication with the FDA, the Companies would plan to submit a New Drug Application (NDA) including data from this study and the first Phase III study for milnacipran around the end of 2007.

About Milnacipran

Milnacipran is the first of a new class of agents known as norepinephrine serotonin reuptake inhibitors, or NSRIs, which exerts its effect by preferentially inhibiting the reuptake of norepinephrine over serotonin, two neurotransmitters known to play an essential role in regulating pain and mood. It has been approved for the treatment of depression in over 32 countries and has been used safely by more than 5 million patients during more than seven years of commercial availability outside the U.S. Milnacipran is being developed for fibromyalgia in the United States market jointly by Forest and its licensor, Cypress Biosciences, Inc.

About Fibromyalgia (FMS)

FMS is a chronic and debilitating condition characterized by widespread pain and stiffness throughout the body, accompanied by severe fatigue, insomnia and mood symptoms. According to the of Rheumatology, FMS is estimated to affect over six million people in the United States. FMS is most often diagnosed in the primary care setting and in addition is the second most commonly diagnosed condition in rheumatology clinics in the United States after osteoarthritis. Despite the high prevalence and severity o
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Point of Care Cardiac Analyzers Yield Rapid Cardiac Marker Results
2. Diagnosing Diabetes: Immediate HbA1c Results Improve Glycemic Control
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
5. Positive Aggrastat Results Featured in the Journal of the American College of Cardiology
6. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
7. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
8. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
9. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
10. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
11. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
Post Your Comments:
(Date:7/31/2015)... India , July 31, 2015 ... CRM solutions for video, data and cloud computing ... with a leading pharma giant for Internet of ... different IoT applications offered on subscription model. ... Pharma giant is striving for business innovations ...
(Date:7/30/2015)... VIEW, Calif. , July 30, 2015 ... it will release its second quarter 2015 financial results ... 2015.   In conjunction with the release, the Company ... at 5:00 p.m. Eastern Time on ... of the quarter and other business developments. ...
(Date:7/30/2015)... you a special edition of #MedicareMonday on Medicare,s 50 th anniversary. As Medicare ... and continue highlighting the success of the prescription drug benefit, commonly referred to as ... latest infographics and videos here: http://onphr.ma/1INp9qQ ... ... ...
Breaking Medicine Technology:Magnaquest Signs a POC With a Leading Pharma Giant in Europe to Manage Subscription Management and Billing for Internet of Things (IoT) 2IRIDEX Announces Second Quarter 2015 Conference Call and Release Date 2Happy 50th Anniversary Medicare! 2Happy 50th Anniversary Medicare! 3
(Date:7/31/2015)... (PRWEB) , ... July 31, 2015 , ... Coco Libre ... athletes, judges, media, and VIPs at the 2015 Vans US Open of Surfing, July ... water that can claim “no added sugar” on the market, is a natural choice ...
(Date:7/31/2015)... ... , ... According to the article published July 27 on My News LA, a ... extinguished by the city’s fire department before it caused major damage throughout the building. The ... fire, and it was a fire alarm system that tipped off fire fighters so they ...
(Date:7/31/2015)... New York, New York (PRWEB) , ... ... ... Nationally renowned trial attorney Jason T. Brown’s live lecture on pharmaceutical negligence ... from July 28th, 2015 was well received with a 94% approval rating ...
(Date:7/31/2015)... ... July 31, 2015 , ... ... event geared to patients and family members, medical professionals, and researchers, covering a ... experts. The conference is a collaborative effort between the Mesothelioma Applied Research Foundation ...
(Date:7/31/2015)... ... July 31, 2015 , ... “Engage: Don’t Just ... industry’s premier thought leadership symposiums, hosted by Massachusetts-based Harmony Healthcare International at ... attracts over 250 “C”-level executives, administrators, directors of nursing, rehabilitation managers and other ...
Breaking Medicine News(10 mins):Health News:Coco Libre Brings Eco-conscious Hydration to Vans US Open of Surfing 2Health News:Article on Recent Pasadena Courtroom Fire Highlights the Effectiveness of Fire Alarm Systems, Says Fire Protection Group Inc 2Health News:Article on Recent Pasadena Courtroom Fire Highlights the Effectiveness of Fire Alarm Systems, Says Fire Protection Group Inc 3Health News:Re-Broadcast of Nationally Renowned Trial Attorney Jason T. Brown's Lecture on Pharmaceutical Negligence Now Available 2Health News:New York Area Mesothelioma Specialists to Present at Conference 2Health News:New York Area Mesothelioma Specialists to Present at Conference 3Health News:Harmony Healthcare International Announces Speaker Line-up for “HARMONY 2015” 2Health News:Harmony Healthcare International Announces Speaker Line-up for “HARMONY 2015” 3
... facilitate care coordination, integration in patient centered medical home practices ( ... ... 2009 -- A new Webinar slated for May 28, 2009, makes ... model for health care transformation: the patient centered medical home. ...
... medical supplies to thousands of home health care providers and individuals ... wide selection of wheelchairs and scooters plus a host of complementary ... ... Providing discount medical supplies to thousands of customers has ...
... Senior Living Inc. (NYSE: BKD ) today announced ... Co-President and Chief Financial Officer, will make a presentation regarding ... 2009 Health Care Conference in New York, NY on Wednesday, ... is being audio webcast live and can be accessed on ...
... VIEJO, Calif., May 11 The Ensign Group, ... company of the Ensign(TM) group of skilled nursing, ... today that it will participate in the Eighth ... 2009 at the Ritz-Carlton in San Francisco. (Logo: ...
... manufacturer of patient-specific medical devices, gains 510k clearance ... of Bolus Electron Conformal Therapy (Bolus ECT(TM)), an ... bolus ECT will be available to users of ... CMS XiO(TM), Varian Eclipse(TM) and Philips Pinnacle3(TM).(Logo: ...
... pm Central Daylight Time) Many physicians are presented ... complaining of chest pain, undergoes a stress test to evaluate ... artery disease, a condition in which plaque builds up inside ... to look at the coronary arteries and despite her symptoms ...
Cached Medicine News:Health News:Health IT Needs of Primary Care Practices Key to Defining "Meaningful Use" of Federal Dollars for Health IT 2Health News:Health IT Needs of Primary Care Practices Key to Defining "Meaningful Use" of Federal Dollars for Health IT 3Health News:Discount Medical Supplies Online Store Announces New Department Dedicated to Wheelchairs and Scooters 2Health News:Discount Medical Supplies Online Store Announces New Department Dedicated to Wheelchairs and Scooters 3Health News:The Ensign Group to Present at the Eighth Annual JMP Securities Research Conference on May 19th 2Health News:The Ensign Group to Present at the Eighth Annual JMP Securities Research Conference on May 19th 3Health News:.decimal, Inc. Gains 510k Clearance from the FDA to Market its p.d(TM) Software for Bolus Electron Conformal Therapy in the United States 2Health News:Study: Women with hard to diagnose chest pain symptoms at higher risk for cardiovascular events 2Health News:Study: Women with hard to diagnose chest pain symptoms at higher risk for cardiovascular events 3
ISI DuraHand is the reusable, easy to sterilize surgical hand immobilizer....
MagPrep® Streptavidin Beads are encapsulated super-paramagnetic polystyrol particles coated with streptavidin. The beads have a diameter of 1 m and are provided as a stabilized aqueous suspensio...
For general purposes...
... is a method for isolating antibodies, ... cells using affinity binding, while retaining ... on the particles to separate biotinylated ... the MagnaBind™ Beads from the suspension, ...
Medicine Products: